This website was developed by Ferring Pharmaceuticals to provide information about erectile dysfunction.

To find out more about us, who we are and what we do, read the page below.

Founded in 1950 by Dr Frederik Paulsen, Ferring Pharmaceuticals is focused on the research and commercial development of peptides – natural compounds that play a role in virtually all of the body’s systems. Ferring produces pharmaceuticals in specific therapeutic areas to help clinicians treat patients on the body’s own terms.

As a dedicated, research-driven biopharmaceutical company, Ferring identifies, develops and markets innovative products in the fields of fertility, obstetrics, endocrinology, urology and gastroenterology. Ferring continues to invest in R&D to enable the introduction of new and enhanced medicines.

At present, there are a number of major projects in the Ferring R&D pipeline, which complement the existing portfolio and offer innovative development of current brands. They also fit neatly into the core expertise areas of peptide chemistry, pharmacology and drug delivery systems. Ferring’s developmental activities are on a global scale and are conducted in collaboration with leading academic centres and teaching hospitals worldwide.

Coordination of development is maintained from the International PharmaScience Center in Copenhagen, Denmark. The accumulated knowledge and experience of Ferring are paving the way for novel compounds that will become tomorrow’s pharmaceuticals.

The following information is for people who have been prescribed Vitaros®. It contains information about what to expect from your medicine and how to administer it.

I confirm I have been
prescribed Vitaros®

Date of Preparation: July 2017 VIT/1841/2017/Uke

The following information is for Health Care Professionals (HCPs). It contains information about why you should prescribe Vitaros and how a patient should apply it.

I confirm I am a Health Care Professional

Date of Preparation: July 2017 VIT/1841/2017/UKf